Legal Psychedelics: Which Compounds Will Be Approved Next? MDMA, LSD Or Something Else?
This article was originally published on Microdose and appears here with permission.
Source: benzinga.com
Liechti Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Liechti Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Liechti Lab Today - Breaking & Trending Today
Mind Medicine MindMed : Company Logo MindMed Investor Presentation August 2023
Company Logo MindMed Investor Presentation August 2023 Disclaimer This presentation has been prepared by Mind Medicine Inc. solely for informational purposes. None of... -Today at 05:35 pm- MarketScreener
Source: marketscreener.com
MindMed Reports First Quarter 2023 Financial Results and Business Highlights
04.05.2023 - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or 'MindMed'), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its financial results for the ...
Source: wallstreet-online.de
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
– Primary endpoint achieved statistically significant improvement in MDD symptoms – – Confirmation of activity of lysergide in brain health disorders with direct relevance to... | April 14, 2023
Source: marketscreener.com
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.
Source: theglobeandmail.com